Bulletin
Investor Alert

Dec. 3, 2021, 7:22 a.m. EST

Time to Revisit Previously Booming CBD Space for Big Growth on Sale (YCBD, TLRY, TPB, MJNA, CWBHF, GWPH, RLBD)

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    cbdMD Inc. (YCBD)
  • X
    PepsiCo Inc. (PEP)

or Cancel Already have a watchlist? Log In

Tilray Inc. /zigman2/quotes/209129655/composite TLRY -2.36% recently announced has launched medical cannabis oral strips in THC and CBD-rich varieties. Powered by QuickStrip's proprietary technology, each Aphria medical strip contains a thin, edible film that contains rapidly dissolving, micronized cannabinoids that absorb directly into the bloodstream, providing patients with a fast-acting, convenient, and precise dosing experience for relief from a range of conditions.

Irwin D. Simon, Tilray's Chairman and Chief Executive Officer, said, "Tilray's medical brands, Aphria, Symbios, and Tilray, are relentlessly committed to investing in patient wellness through a portfolio of new innovative product offerings, GMP-certified cultivation, and the earned trust of the medical community. The launch of the Aphria-branded medical strips is a compelling proof point in this regard, and, given the growing expansion of medical cannabis across the globe, we believe we are exceptionally well-positioned in this high-growth, high-margin market moving forward. We look forward to extending our leadership in medical cannabis and to delivering value for patients and shareholders alike."

While this is a clear factor, it has been incorporated into a trading tape characterized by a pretty dominant offer, which hasn't been the type of action TLRY shareholders really want to see. In total, over the past five days, shares of the stock have dropped by roughly -12% on above average trading volume. All in all, not a particularly friendly tape, but one that may ultimately present some new opportunities.

Tilray Inc. /zigman2/quotes/209129655/composite TLRY -2.36% managed to rope in revenues totaling $168M in overall sales during the company's most recently reported quarterly financial data — a figure that represents a rate of top line growth of 222.5%, as compared to year-ago data in comparable terms. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($376.3M against $526.8M, respectively).

Other key plays in the CBD space include Medical Marijuana Inc. /zigman2/quotes/210250025/delayed MJNA -1.26% and Charlotte's Web Holdings Inc. /zigman2/quotes/205374221/delayed CWBHF -1.50% .

Please make sure to read and completely understand our disclaimer at https://www.wallstreetpr.com/disclaimer . We may be compensated for posting this content on our website by EDM Media LLC. For questions, comments or suggestions please contact ir@edm.media.

The post Time to Revisit Previously Booming CBD Space for Big Growth on Sale (YCBD, TLRY, TPB, MJNA, CWBHF, GWPH, RLBD) appeared first on Wall Street PR .

COMTEX_398226240/2770/2021-12-03T07:22:24

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

/zigman2/quotes/209129655/composite
US : U.S.: Nasdaq
$ 4.55
-0.11 -2.36%
Volume: 30.42M
May 27, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$2.32 billion
Rev. per Employee
$253,146
loading...
/zigman2/quotes/209129655/composite
US : U.S.: Nasdaq
$ 4.55
-0.11 -2.36%
Volume: 30.42M
May 27, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$2.32 billion
Rev. per Employee
$253,146
loading...
/zigman2/quotes/210250025/delayed
US : U.S.: OTC
$ 0.02
-0.0002 -1.26%
Volume: 4.83M
May 27, 2022 3:55p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$61.16 million
Rev. per Employee
N/A
loading...
/zigman2/quotes/205374221/delayed
US : U.S.: OTC
$ 0.44
-0.0067 -1.50%
Volume: 246,619
May 27, 2022 3:59p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$64.66 million
Rev. per Employee
$355,896
loading...

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.